It’s no secret that pharmaceutical manufacturers and payers don’t always see eye to eye.

But in order for pharma market access to do its job it needs to better understand payers -- how  they think, what keeps them up at night, and what’s trending.

That’s why Valuate conducted its Second Annual Market Access survey late last year. The goal was to better understand payer perspectives on everything from the Inflation Reduction Act to biosimilars to gold bagging. 

Tony Gibson, a Principal with Valuate Health, returns to The IDI to break down the results. You can also contact Tony if you want an exclusive readout of the survey.

Follow Tony on  LinkedIn. 

Follow Valuate on LinkedIn

Learn more about Valuate.